KR7207940008
KR7207940008
SAMSUNG BIOLOGICS
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 56.75T EUR | 64.55T EUR | 72.69T EUR | 78.46T EUR |
Enterprise Value | 55.39T EUR | 65.5T EUR | 73.36T EUR | 79.24T EUR |
Valuation Multiples | ||||
Trailing P/E | -- | 32.53x | 38.7x | 55.7x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 11.08x | 14.2x | 17.14x | 26.3x |
Price to Book | -- | 7.72x | 9.17x | 10.53x |
EV/Revenue | 10.82x | 14.41x | 17.3x | 26.56x |
EV/EBITDA | 19.59x | 22.04x | 25.38x | 36.88x |
Price to FCF (P/FCF) | 43.81x | 40.99x | 51.35x | 106.12x |
EV/FCF | 42.77x | 41.6x | 51.83x | 107.18x |
FCF Yield | 2.28% | 2.44% | 1.95% | 0.94% |